Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T22:43:18.078Z Has data issue: false hasContentIssue false

Expansion of spatial and host range of Puumala virus in Sweden: an increasing threat for humans?

Published online by Cambridge University Press:  02 March 2017

O. BORG
Affiliation:
Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden
M. WILLE*
Affiliation:
Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden
P. KJELLANDER
Affiliation:
Department of Ecology, Grimsö Wildlife Research Station, Swedish University of Agricultural Sciences, SLU, Riddarhyttan, Sweden
U. A. BERGVALL
Affiliation:
Department of Ecology, Grimsö Wildlife Research Station, Swedish University of Agricultural Sciences, SLU, Riddarhyttan, Sweden Department of Zoology, Stockholm University, Stockholm, Sweden
P.-E. LINDGREN
Affiliation:
Department of Clinical and Experimental Medicine, Medical Microbiology, Linköping University, Linköping, Sweden Microbiological Laboratory, Medical Services, County Hospital Ryhov, Jönköping, Sweden
J. CHIRICO
Affiliation:
National Veterinary Institute, SVA, Uppsala, Sweden
Å. LUNDKVIST*
Affiliation:
Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden Department of Medical Sciences, Uppsala University and Laboratory of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden
*
*Authors for correspondence: Å. Lundkvist and M. Wille, Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden. (Email: Åke.Lundkvist@imbim.uu.se and Michelle.Wille@imbim.uu.se)
*Authors for correspondence: Å. Lundkvist and M. Wille, Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden. (Email: Åke.Lundkvist@imbim.uu.se and Michelle.Wille@imbim.uu.se)
Rights & Permissions [Opens in a new window]

Summary

Hantaviruses are globally distributed and cause severe human disease. Puumala hantavirus (PUUV) is the most common species in Northern Europe, and the only hantavirus confirmed to circulate in Sweden, restricted to the northern regions of the country. In this study, we aimed to further add to the natural ecology of PUUV in Sweden by investigating prevalence, and spatial and host species infection patterns. Specifically, we wanted to ascertain whether PUUV was present in the natural reservoir, the bank vole (Myodes glareolus) further south than Dalälven river, in south-central Sweden, and whether PUUV can be detected in other rodent species in addition to the natural reservoir. In total, 559 animals were collected at Grimsö (59°43′N; 15°28′E), Sala (59°55′N; 16°36′E) and Bogesund (59°24′N; 18°14′E) in south-central Sweden between May 2013 and November 2014. PUUV ELISA-reactive antibodies were found both in 2013 (22/295) and in 2014 (18/264), and nine samples were confirmed as PUUV-specific by focus reduction neutralization test. Most of the PUUV-specific samples were from the natural host, the bank vole, but also from other rodent hosts, indicating viral spill-over. Finally, we showed that PUUV is present in more highly populated central Sweden.

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2017 

INTRODUCTION

Hantaviruses are single-stranded, negative-sense RNA viruses belonging to the family Bunyaviridae [Reference Plyusnin and King1]. These constitute a widespread group of viruses, and several are zoonotic agents with great impact on public health [Reference Kahlon2]. Hantaviruses are the major causative agents of two severe human diseases: hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS) [Reference Lee and van der Groen3, Reference Jonsson, Figueiredo and Vapalahti4]. Geographically, HFRS is mainly limited to Eurasia while HCPS is restricted to the Americas. Approximately, 10 000 cases of human HFRS are diagnosed annually in Europe [Reference Jonsson, Figueiredo and Vapalahti4, Reference Reusken and Heyman5], about 150 000–200 000 cases throughout the world, although there are likely thousands of cases that are never reported [Reference Kruger6Reference Vaheri8]. Further, the number of HFRS cases are increasing, although the drivers of this phenomenon are unclear. Factors may range from increased surveillance to climatic factors [Reference Heyman, Vaheri and Members9, Reference Schwarz10], including a shift in host distribution and behavior as a result of climate change [Reference Reusken and Heyman5]. The clinical manifestation differs between hantaviruses, where Puumala virus (PUUV) causes less severe human diseases compared with other more pathogenic hantavirus species [Reference Bi, Formenty and Roth11]. However, all pathogenic hantavirus infections have a similar initial clinical presentation; mainly influenza-like illness, with symptoms including myalgia, malaise and high fever [Reference Vaheri12]. Virus transmission to humans occurs through inhalation of virus-contaminated aerosol from rodent excreta. Humans are most likely exposed to virus-contaminated aerosol through dust or handling hay/timber that has been in close contact with the hosts. Furthermore, there is a strong correlation between human infections and the number of infected rodents circulating in the same area [Reference Olsson13, Reference Pettersson14]. Rodent-to-rodent transmission occurs through both indirect (aerosol) and direct (contact) transmission [Reference Olsson13Reference Voutilainen15].

Hantaviruses constitute a large group of viruses with global distribution, reflecting the distribution of host reservoirs. There has been an increased focus on wild rodents as reservoirs for hantaviruses in Europe due to recent detections of Seoul virus (SEOV) in wild rats combined with severe SEOV-caused human HFRS cases. Specifically, SEOV has recently been detected in England [Reference Lundkvist16], France [Reference Heyman17], and the Netherlands [Reference Verner-Carlsson18]. Furthermore, SEOV was found in Swedish pet rats that originated from England [Reference Lundkvist16]. Globally, more than 20 distinct species of hantaviruses have been described, and each virus species is spread by one specific mammalian host as a result of long-term co-evolution [Reference Dearing and Dizney19Reference Vapalahti21]. This hypothesis is supported by phylogenetic studies, whereby the genetic relationship between host and virus diversification is mirrored [Reference Morzunov22Reference Plyusnin and Sironen24]. Although rodents constitute the majority of hosts, hantaviruses might have first appeared in Chiroptera (bats) or Soricomorpha (moles and shrews), before emerging in rodent species [Reference Zhang25].

The natural reservoir host for PUUV, the most common hantavirus circulating in central and northern Europe, is the bank vole Myodes glareolus. PUUV is currently the only hantavirus known to circulate in Sweden, and is endemic in the northern parts of the country [Reference Olsson13, Reference Olsson26]. The current hypothesis is that PUUV is endemic only north of the river Dalälven, located north of the most urbanized regions of Sweden [Reference Olsson26, Reference Olsson, Leirs and Henttonen27]. This is reflected by the lack of human cases of south of the river Dalälven, however, recent sampling of rodents has suggested this may no longer be correct [Reference Olsson13, Reference Lohmus28]. In this study, we aimed to further add to the ecology of PUUV in Sweden by investigating prevalence, spatial, and host species infection patterns. Specifically, we wanted to ascertain the prevalence and distribution of hantaviruses in Swedish rodents south of the river Dalälven, and assess the host range of PUUV in rodent species in addition to the natural reservoir in this region.

METHODS

Sampling strategy and ethics statement

All trapping and sampling was carried out in accordance with Swedish and European law and regulations provided by the Swedish Board of Agriculture. The capture and sampling protocols were approved by the Animal Experiment Ethical Committee, Umeå, (Reference: A13–14). All trapping and sampling was conducted by trained biologists.

Study sites and sample collection

Rodents were captured between May 2013 – November 2014 from three geographical locations south of the river Dalälven: Sala (59°55′N, 16°36′E), Grimsö (59°43′N, 15°28′E), and Bogesund (59°24′N, 18°14′E) (Figure 1). These geographic locations represent three different ecotypes. Both Sala and Grimsö are inland, however where Grimsö is more forested, the area around Sala is mostly agricultural. Furthermore, at the time of sampling the area around Sala had been heavily affected by a large fire, resulting in a disturbed landscape. Bogesund is in close proximity to the Baltic Sea and has a more rocky terrain. Rodents were captured using commercially available snap-traps. Following capture, carcasses were frozen to ⩽−20°C within 2 h of collection. In the laboratory, the rodents were defrosted and were dissected. Partial spleen and heart tissues were collected and frozen in −80°C until required for analysis. Other tissues were collected from the rodents for a number of other studies, and the carcasses were appropriately disposed following dissections.

Fig. 1. Locations from which small mammals were collected in this study. Sample sites are indicated in black. Stockholm, the largest city in Sweden, and Uppsala, Sweden's fifth largest city are indicated with a gray marker have been included for reference.

Serological screening

Enzyme-linked immunosorbent assay (ELISA)

Tissues were subdivided into smaller pieces of approximately 25 g, and homogenized in phosphate buffered saline (PBS) (using a beater for 3 min in PBS). The homogenate was initially assayed using a hantavirus IgG ELISA, based on baculovirus-expressed PUUV nucleocapsid protein antigen [Reference Vapalahti29], as previously described for use on serum samples [Reference Sjolander30]. This method has been validated and successfully used previously with organ homogenates [e.g. Reference Lundkvist16, Reference Verner-Carlsson18].

Focus reduction neutralization test (FRNT)

To confirm hantavirus-specificity, the ELISA-positive samples were further evaluated by FRNT, the gold standard for hantavirus serology [Reference Lundkvist31]. Briefly, a new subsection of tissue was homogenized as described above, initially extracted in PBS (1:25). The homogenate was further diluted (1:2) in 1x Hanks balanced serum solution (Corning, New York, USA), mixed with diluted virus (PUUV strain Kazaan-E6) [Reference Lundkvist31] and added to confluent Vero E6 cell monolayers in six-well tissue culture plates. After 7 days, a solution of monkey anti-PUUV polyclonal serum in 5% Fetal Calf Serum (Gibco, Thermo Fisher, Boston, USA) and wash buffer (0.15% Tween 20 in PBS) was added and incubated. Virus-infected cells were visualized by addition of peroxidase-labelled goat anti-human IgG (Bio-Rad Laboratories, Hercules, CA), followed by terminative 3, 3′, 5, 5′-tetramethylbenzidine substrate (Sigma, Stockholm, Sweden). The FRNT-positive samples from 2014 were further titrated (1:50 to 1:800) to ascertain the minimal dilution of rodent tissues to avoid non-specific inhibition. FRNT results are presented in percentages, representing the percentage reduction of the number of foci. A dilution series of infected Vero E6 cells were used as a positive control, and, 80% reduction of the number of foci was selected as the cut-off for the virus neutralization titer.

RESULTS

A total of 559 animals were screened for PUUV reactive antibodies across three locations, south of the putative PUUV geographical boarder. Roughly similar numbers of organs were screened in 2013 and 2014, however, in 2013 all 295 samples were homogenates from spleens, as compared with 187 hearts and 77 spleens in 2014. More than 50% of samples collected were from bank vole (n = 342), and PUUV reactive antibody prevalence in bank vole was 7·6% with no significant difference in prevalence between 2013 and 2014 (Fisher Exact Test; χ 2 = 1·237, df = 1, P = 0·266). However, a number of other species were also positive including pygmy shrew (Sorex minutus, 25%), common shrew ( Sorex araneus, 3·1%), yellow-necked mouse (Apodemus flavicollis, 11·6%), wood mouse (Apodemus sylvaticus; 16·7%) and a neonate roe deer (Capreolus capreolus, 9%). While antibody prevalence appeared higher in yellow-necked mouse and pygmy shrew as compared with bank vole, sample size for these species was much smaller. Species tested but not positive included Eurasian water shrew (Neomys fodiens), field vole (Microtus agrestis), wood lemming (Myopus schisticolor), and three avian species. Different locations appeared to have different importance for different species, however sampling bias did not allow for comparisons except for bank voles and yellow-necked mouse. For bank vole, PUUV antibody prevalence was higher in Bogesund (Fisher Exact Test; χ 2 = 8·787, df = 1, P = 0·003) and Grimsö (Fisher Exact Test; χ 2 = 4·26, df = 1, P = 0·04) than Sala. In contrast, yellow-necked mice in Sala had a higher prevalence (18·2%) than Bogesund (0·5%), however due to small sample sizes this is not significant (Fisher Exact Test; χ 2 = 3·634, df = 1, P = 0·056) (Table 1).

Table 1. ELISA prevalence and number of samples collected from locations south of the river Dalälven in 2013–2014 in Sweden

NT, not tested.

Subsequently, all ELISA positives were assayed by FRNT to confirm hantavirus-specificity. Diluting homogenates prior to FRNT analysis proved crucial; homogenates from 2014 were serially diluted and revealed that a minimal dilution for a reliable result was 1:100 for this sample type (antibodies extracted from rodent spleens and hearts). The dilution 1:50, used in 2013, was insufficient to avoid the possibility of non-specific inhibition, which would result in potentially false positive outcomes. Thus, FRNT confirmation from the 2013 samples is tentative, however we infer that 5 of the 22 ELISA positives in 2013 reacted at 1:50 by FRNT dilution; roe deer (n = 1), common shrew (n = 1) and bank voles (n = 3). In 2014, nine ELISA positives were confirmed by FRNT, limited to bank voles from Bogesund (5/56 tested), a wood mouse in Bogesund (1/2 tested) and yellow-necked mice in Sala (3/22 tested). Interestingly, one yellow-necked mouse (Sample 134, 2014) had a FRNT end-point titer of ⩾1:800 (Table 2).

Table 2. FRNT neutralization of ELISA-positive samples from small mammals collected in 2014

* FRNT result at 1:100 dilution of <20% indicates a positive result.

Percentage of foci as compared with virus control.

Not tested.

DISCUSSION

Emerging and re-emerging pathogens are among the greatest challenges of the 21st century, and present a large economic burden to society. Further, most emerging and remerging pathogens are zoonotic viruses; viruses with natural hosts in the animal reservoir [Reference Jones32Reference Woolhouse and Gowtage-Sequeria34]. European studies indicate that hantaviruses are not only spreading to new areas [Reference Heyman17, Reference Verner-Carlsson18], but also to new hosts [Reference Eckerle, Lenk and Ulrich35]. In this study, we aimed to assess the dynamics of hantaviruses in Sweden, by assessing virus diversity and prevalence, spatial distribution, and host species fidelity through antibodies. Spatially, the current working hypothesis is that PUUV in Sweden is endemic north of the river Dalälven [Reference Olsson26, Reference Olsson, Leirs and Henttonen27], however both this study and Lohmus et al. [Reference Lohmus28] clearly demonstrated PUUV infections in bank voles south of this boarder. We found positive rodents from Grimsö, Sala and Bogesund, captured in both 2013 and 2014, however, different areas were more important for different species. Reactive antibody prevalence was highest in Grimsö and Bogesund in bank vole; the Sala landscape, which is mostly agricultural was devastated by a large fire during the sampling period of this study. How this affects PUUV antibody prevalence is uncertain. In contrast, Sala was more important for yellow-necked mouse. The role of habitat for disease risk is complex, but a recent review suggests that there is a strong correlation between habitat and disease prevalence. Specifically, factors such as forest cover, fires, fragmentation and barrow space influence the dispersal of voles (and in this case mice), consequently affecting the epidemiology of PUUV [Reference Jonsson, Figueiredo and Vapalahti4, Reference Dearing and Dizney19, Reference Khalil36, Reference Salvador37]. The Bogesund site is of particular interest as it is both the most southern site of this study and a location with high PUUV prevalence in bank voles. This range expansion of PUUV in wildlife reservoirs has yet to result in numerous human cases. A similar trend is evident in France, where PUUV has been detected in voles in populated regions with no human cases of HFRS, however in this case it is suggested to be driven by specific amino acid differences in the viruses [Reference Castel38]. Regardless, expansion of PUUV into areas with a higher human population is concerning in context of public health.

Not only did we detect an expansion in the known PUUV geographic range, we also illustrate an increase in host range following detection of PUUV reactive antibodies in a number of permissive species. Yellow-necked mouse, wood mouse, common shrew and pygmy shrew were found among the ELISA-positive samples; in total 37% of ELISA-reactive samples were from species other than bank vole, indicating PUUV spill-over to other rodent and shrew species, or the presences of an unknown hantavirus causing cross-reacting antibodies detected by ELISA. Yellow-necked mouse has previously been shown to be a permissive host for PUUV in Sweden [Reference Lohmus28], but we found ELISA reactive antibodies in most species tested (given a large enough sample size), with the exception of field vole. While rodents, specifically mice are plausible spill-over hosts, detection of PUUV-reactive antibodies from a roe deer is unusual. The actual hantavirus species infecting Swedish shrews awaits further investigations. Given the numerous shrew-carried hantaviruses discovered during the last decade [Reference Kruger6, Reference Vaheri8], it is likely that one or several of these species are also circulating in Sweden, although PUUV spill-over events cannot be excluded at this stage. Given the deviation from known hantavirus host range, a more in depth analysis of shrews and ungulates ranging from sampling to virus sequencing is warranted. Indeed, Ahlm et al., described hantavirus-infected moose from northern Sweden [Reference Ahlm39], thus ungulates appear permissive to PUUV infection, but whether they are dead-end hosts or not is unknown. Hantaviruses are considered to be host-specific [Reference Vapalahti21], however, this study revealed unexpected spill-over to a spectrum of different rodents, corroborating the hypothesis that PUUV epidemiology may be more complex [Reference Sjolander30, Reference Klingstrom40, Reference Schmidt-Chanasit41].

Based upon our results, and emerging evidence [Reference Sjolander30, Reference Klingstrom40, Reference Schmidt-Chanasit41], strict host fidelity in this system seems unlikely. The role that these spill-over hosts play in the epidemiology is, however unclear; they are indeed permissive to infection, and given the detection levels in this study, these spill-over events are not rare. In order to reveal the role of putative spill-over hosts play in the epidemiology of PUUV we need to ascertain whether they are dead-end hosts, spill-over hosts, or are able to transmit infection. Regardless, it is likely that PUUV potentially has lower fitness in species other than bank voles, which may in turn limit frequency of infections. This potentially expanded model of PUUV (and hantavirus) epidemiology has large implications for the mitigation of human hantavirus-derived disease cases, as more hosts increase the risk for human transmission. This is further compounded with range expansion into more populated regions of Sweden. If these phenomena result in endemicity in new hosts or geographic regions, the health burden caused by hantaviruses will certainly increase.

CONCLUSIONS

Studies such as these are imperative in ascertaining PUUV prevalence in wildlife hosts to better inform risk areas for human infections. Given an expansion of PUUV range in the wildlife host, surveillance in humans is prudent. PUUV hantavirus is a putatively emerging virus in Sweden, with detections of antibodies against PUUV in both the reservoir and other small mammals farther south than previously described. Specifically, PUUV is now detected in more densely populated areas, as described here, in close proximity to large cities such as Uppsala and Stockholm. Moreover, rodents such as yellow-necked mouse utilize anthropogenic buildings 10 times more frequently than bank voles [Reference Lohmus28]. These two factors rapidly decrease distance, and thus increase interactions, between humans and the wildlife reservoir. This may have large implications, as it increases the probability of human contact with infected rodent excreta, creating a large reservoir for potential hantavirus infections in humans.

ACKNOWLEDGEMENTS

This study was partially funded by EU grant FP7-261504 EDENext and is cataloged by the EDENext Steering Committee as (http://www.edenext.eu). This work was supported by the Swedish Environmental Protection Agency project (P.K.), the Swedish Hunters Organization (P.K.) and the foundation Marie-Claire Cronstedt stiftelse (P.K.) and by EU Interreg – ScandTick Innovation (P.K. and P.E.L.). The funding sources had no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the paper for publication. The authors would like to acknowledge Madeleine Christensson for organizing all fieldwork and the personnel for collecting various mammals used in this study. They also acknowledge Torsten Berg and Jonas Nordström for important contribution to fieldwork.

DECLARATION OF INTEREST

None.

ETHICAL STANDARDS

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals.

References

REFERENCES

1. Plyusnin, A, et al. Family Bunyaviridae. In: King, AMQ, et al. , eds. Virus Taxonomy–Ninth Report of the International Committee on Taxonomy of Viruses. London, UK: Elsevier/Academic Press, 2011, pp. 725741.Google Scholar
2. Kahlon, S. Viral hemorrhagic fever: Bunyaviridae. Current Treatment Options in Infectious Diseases 2015; 7(3): 240247.CrossRefGoogle Scholar
3. Lee, HW, van der Groen, G. Hemorrhagic fever with renal syndrome. Progress in Medical Virology 1989; 36: 62102.Google Scholar
4. Jonsson, CB, Figueiredo, LT, Vapalahti, O. A global perspective on hantavirus ecology, epidemiology, and disease. Clinical Microbiology Reviews 2010; 23: 412441.CrossRefGoogle Scholar
5. Reusken, C, Heyman, P. Factors driving Hantavirus emergence in Europe. Current Opinions in Virology 2013; 3(1): 9299.CrossRefGoogle ScholarPubMed
6. Kruger, DH, et al. Hantaviruses–globally emerging pathogens. Journal of Clinical Virology 2015; 64: 128136.Google Scholar
7. Avsic-Zupanc, T, Saksida, A, Korva, M. Hantavirus infections. Clinical Microbiology and Infection 2015. doi: 10.1111/1469-0691.12291.Google Scholar
8. Vaheri, A, et al. Hantavirus infections in Europe and their impact on public health. Reviews in Medical Virology 2013; 23(1): 3549.CrossRefGoogle ScholarPubMed
9. Heyman, P, Vaheri, A, Members, E. Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Eurosurveillance 2008; 13(28): 717727.CrossRefGoogle ScholarPubMed
10. Schwarz, AC, et al. Risk factors for human infection with Puumala virus, southwestern Germany. Emerging Infectious Diseases 2009; 15: 10321039.Google Scholar
11. Bi, Z, Formenty, PB, Roth, CE. Hantavirus infection: a review and global update. Journal of Infection in Developing Countries 2008; 2: 323.Google Scholar
12. Vaheri, A, et al. Uncovering the mysteries of hantavirus infections. Nature Reviews Microbiology 2013; 11: 539550.Google Scholar
13. Olsson, GE, et al. Predicting high risk for human hantavirus infections, Sweden. Emerging Infectious Diseases 2009; 15: 104106.CrossRefGoogle ScholarPubMed
14. Pettersson, L. Transmission and Pathogenesis of Hantavirus. Umeå University Dissertation Series, Umeå, Sweden. ISBN: 978-91-7601-225-3; 2015.Google Scholar
15. Voutilainen, L, et al. Life-long shedding of Puumala hantavirus in wild bank voles (Myodes glareolus). Journal of General Virology 2015; 96: 12381247.Google Scholar
16. Lundkvist, A, et al. Pet rat harbouring Seoul hantavirus in Sweden, June 2013. Eurosurveillance 2013; 18.Google Scholar
17. Heyman, P, et al. Seoul hantavirus in Europe: first demonstration of the virus genome in wild Rattus norvegicus captured in France. European Journal of Clinical Microbiology and Infectious Disease 2004; 23: 711717.Google Scholar
18. Verner-Carlsson, J, et al. First evidence of Seoul hantavirus in the wild rat population in the Netherlands. Infection, Ecology and Epidemiology 2015; 5: 27215.Google Scholar
19. Dearing, MD, Dizney, L. Ecology of hantavirus in a changing world. Annals of the New York Academy of Sciences 2010; 1195: 99112.Google Scholar
20. Henttonen, H, et al. Recent discoveries of new hantaviruses widen their range and question their origins. Annals of the New York Academy of Sciences 2008; 1149: 8489.CrossRefGoogle ScholarPubMed
21. Vapalahti, O, et al. Hantavirus infections in Europe. Lancet Infect Disease 2003; 3: 653661.Google Scholar
22. Morzunov, SP, et al. Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. Journal of Virology 1998; 72: 5764.CrossRefGoogle ScholarPubMed
23. Plyusnin, A, Morzunov, SP. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Current Topics in Microbiology and Immunology 2001; 256: 4775.Google ScholarPubMed
24. Plyusnin, A, Sironen, T. Evolution of hantaviruses: co-speciation with reservoir hosts for more than 100 MYR. Virus Research 2014; 187: 2226.Google Scholar
25. Zhang, YZ. Discovery of hantaviruses in bats and insectivores and the evolution of the genus Hantavirus. Virus Research 2014; 187: 1521.Google Scholar
26. Olsson, GE, et al. Human hantavirus infections, Sweden. Emerging Infectious Diseases 2003; 9: 13951401.CrossRefGoogle ScholarPubMed
27. Olsson, GE, Leirs, H, Henttonen, H. Hantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Disease 2010; 10(6): 549561.Google Scholar
28. Lohmus, M, et al. Hantavirus in new geographic regions, Sweden. Infection, Ecology and Epidemiology 2016; 6: 31465.Google Scholar
29. Vapalahti, O, et al. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. Journal of Clinical Microbiology 1996; 34: 119125.Google Scholar
30. Sjolander, KB, et al. Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica). Journal of Clinical Microbiology 1997; 35: 32643268.CrossRefGoogle ScholarPubMed
31. Lundkvist, A, et al. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. Journal of Medical Virology 1997; 53: 5159.Google Scholar
32. Jones, KE, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990993.Google Scholar
33. Woolhouse, ME. Population biology of emerging and re-emerging pathogens. Trends in Microbiology 2002; 10: S3S7.Google Scholar
34. Woolhouse, ME, Gowtage-Sequeria, S. Host range and emerging and reemerging pathogens. Emerging Infectious Diseases 2005; 11: 18421847.CrossRefGoogle ScholarPubMed
35. Eckerle, I, Lenk, M, Ulrich, RG. More novel hantaviruses and diversifying reservoir hosts--time for development of reservoir-derived cell culture models? Viruses 2014; 6: 951967.Google Scholar
36. Khalil, H, et al. Dynamics and drivers of hantavirus prevalence in rodent populations. Vector Borne Zoonotic Disease 2014; 14(8): 537551.CrossRefGoogle ScholarPubMed
37. Salvador, AR, et al. Concomitant influence of helminth infection and landscape on the distribution of Puumala hantavirus in its reservoir, Myodes glareolus . BMC Microbiology 2011; 11:30. doi: 10.1186/1471-2180-11-30.CrossRefGoogle ScholarPubMed
38. Castel, G, et al. Complete genome and phylogeny of Puumala hantavirus isolates circulating in France. Viruses 2015; 7(10): 54765488.CrossRefGoogle ScholarPubMed
39. Ahlm, C, et al. Serologic evidence of Puumala virus infection in wild moose in northern Sweden. American Journal of Tropical Medicine and Hygiene 2000; 62: 106111.Google Scholar
40. Klingstrom, J, et al. Rodent host specificity of European hantaviruses: evidence of Puumala virus interspecific spillover. Journal of Medical Virology 2002; 68: 581588.Google Scholar
41. Schmidt-Chanasit, J, et al. Extensive host sharing of central European Tula virus. Journal of Virology 2010; 84: 459474.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Locations from which small mammals were collected in this study. Sample sites are indicated in black. Stockholm, the largest city in Sweden, and Uppsala, Sweden's fifth largest city are indicated with a gray marker have been included for reference.

Figure 1

Table 1. ELISA prevalence and number of samples collected from locations south of the river Dalälven in 2013–2014 in Sweden

Figure 2

Table 2. FRNT neutralization of ELISA-positive samples from small mammals collected in 2014